Harnessing the potential of machine learning for advancing “Quality by Design” in biomanufacturing
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Ensuring consistent high yields and product quality are key challenges in biomanufacturing. Even minor deviations in critical process parameters (CPPs) such as media and feed compositions can significantly affect product critical quality attributes (CQAs). To identify CPPs and their interdependencies with product yield and CQAs, design of experiments, and multivariate statistical approaches are typically used in industry. Although these models can predict the effect of CPPs on product yield, there is room to improve CQA prediction performance by capturing the complex relationships in high-dimensional data. In this regard, machine learning (ML) approaches offer immense potential in handling non-linear datasets and thus are able to identify new CPPs that could effectively predict the CQAs. ML techniques can also be synergized with mechanistic models as a 'hybrid ML' or 'white box ML' to identify how CPPs affect the product yield and quality mechanistically, thus enabling rational design and control of the bioprocess. In this review, we describe the role of statistical modeling in Quality by Design (QbD) for biomanufacturing, and provide a generic outline on how relevant ML can be used to meaningfully analyze bioprocessing datasets. We then offer our perspectives on how relevant use of ML can accelerate the implementation of systematic QbD within the biopharma 4.0 paradigm.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Learning representations by back-propagating errors
Rumelhart, D. E., Hinton, G. E., & Williams, R. J. (1986) · Nature · doi:10.1038/323533a0 · Cited by 31,892
Highly accurate protein structure prediction for the human proteome
Tunyasuvunakool, K., Adler, J., Wu, Z., Green, T., Zielinski, M., Žídek, A., Bridgland, A., Cowie, A., Meyer, C., Laydon, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03828-1 · Cited by 3,025 · cited 1×
“69 However, to achieve the same ML performance for CQA prediction of a protein therapeutic from their sequence, measurements from bioreactor should also be considered.”
BackgroundProduction of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032 · cited 1×
“Unlike small molecules, biopharmaceuticals are large, complex drugs that are typically produced using live mammalian cells.(2) The biological activity of biopharmaceuticals is extremely sensitive to variations in their critical quality attributes (CQAs), such as the N-glycosylation, charge distribution and aggregation.”
BackgroundGoetze, A. M., Liu, Y. D., Zhang, Z., Shah, B., Lee, E., Bondarenko, P. V., & Flynn, G. C. (2011) · Glycobiology · doi:10.1093/glycob/cwr027 · Cited by 467
Reduced elimination of IgG antibodies by engineering the variable region
Igawa, T., Tsunoda, H., Tachibana, T., Maeda, A., Mimoto, F., Moriyama, C., Nanami, M., Sekimori, Y., Nabuchi, Y., Aso, Y., et al. (2010) · Protein Engineering Design and Selection · doi:10.1093/protein/gzq009 · Cited by 265 · cited 1×
“2 6 The biopharmaceutical product quality is also extremely sensitive to changes in the underlying biomanufacturing operating conditions and raw materials.”
BackgroundMultivariate analysis of cell culture bioprocess data—Lactate consumption as process indicator
Le, H., Kabbur, S., Pollastrini, L., Sun, Z., Mills, K., Johnson, K., Karypis, G., & Hu, W.-S. (2012) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2012.08.021 · Cited by 177 · cited 2×
“…glutamate, other amino acids) on various process outcomes such as viable cell density (VCD)/cell growth, 23,31–33 titer, 17,19,22,23,25,32–35 toxic by-product (lactate and ammonia) accumulation, 23,31,34 and CQAs such as N-glycosylation, 17,18,21,22,25,35,36 aggregation, 17,18 and charge variants.”
BackgroundMethodModel-based optimization of antibody galactosylation in CHO cell culture
Kotidis, P., Jedrzejewski, P., Sou, S. N., Sellick, C., Polizzi, K., del Val, I. J., & Kontoravdi, C. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.26960 · Cited by 90
Aghamohseni, H., Ohadi, K., Spearman, M., Krahn, N., Moo-Young, M., Scharer, J. M., Butler, M., & Budman, H. M. (2014) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2014.05.024 · Cited by 75 · cited 3×
“53 Recently, Kotidis and Kontravadi developed a hybrid model whereby ANNs and kinetic model were merged to link the key CQA, N-glycosylation, with cellular metabolism.”
Background
Cited by
Bioprocessing 4.0 in Biomanufacturing: Paving the Way for Sustainable Bioeconomy
Pandey, K., Pandey, M., Kumar, V., Aggarwal, U., & Singhal, B. (2024) · Systems Microbiology and Biomanufacturing · doi:10.1007/s43393-023-00206-y · Cited by 58
“Therefore, artificial intelligence (AI)-based machine learning (ML) approaches such as neural networks, support vector machines and hybrid modeling such as intensified design of experiments (DoE) have gained momentum [9].”
Dan, A., Liu, B., Patil, U., Manuraj, B. N. M., Gandhi, R., Buchel, J., Chundawat, S. P. S., Guo, W., & Ramachandran, R. (2025) · Control Engineering Practice · doi:10.1016/j.conengprac.2024.106198 · Cited by 20
Hybrid modeling for in silico optimization of a dynamic perfusion cell culture process
Agarwal, P., McCready, C., Ng, S. K., Ng, J. C., van de Laar, J., Pennings, M., & Zijlstra, G. (2025) · Biotechnology Progress · doi:10.1002/btpr.3503 · Cited by 14
Self-citationTanaka, M., Araujo, A. C., Valenti, V. E., Guiguer, E. L., Catharin, V. C. S., Gualhardi, C. M., de Souza Bastos Mazuqueli Pereira, E., de Alvares Goulart, R., de Argolo Haber, R. S., de Carvalho, A. C. A., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052370 · Cited by 13
Metadata
- Authors
- Walsh, I., Myint, M., Nguyen-Khuong, T., Ho, Y. S., Ng, S. K., & Lakshmanan, M.
- Venue
- mAbs
- Publisher
- Informa UK Limited
- Published
- 2022-01-09
- Volume
- 14
- Issue
- 1
- Pages
- 2013593-2013593
- ISSN
- 1942-0862 (ISSN-L)
- 1942-0870
- OpenAlex
- W4206492149
- Cited by
- 81
- References
- 14
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Harnessing the potential of machine learning for advancing “Quality by Design” in biomanufacturing. https://app.cochat.ai/papers/10.1080/19420862.2021.2013593
- The paper
- Walsh, I., Myint, M., Nguyen-Khuong, T., Ho, Y. S., Ng, S. K., & Lakshmanan, M. (2022). Harnessing the potential of machine learning for advancing “Quality by Design” in biomanufacturing. mAbs. https://doi.org/10.1080/19420862.2021.2013593
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.